Sensei Biotherapeutics
Rockville, US · Delaware corporation · 2 known investors
Find your way into Sensei Biotherapeutics
Founders & leadership
KH
Kristian HumerExecutive
CG
Christopher GerryExecutive
AK
Anand Kiran ParikhExecutive
JC
Josiah CraverExecutive
Board
BH
Bob HolmenBoard director
PB
Phillip B. DonenbergBoard director
TR
Tom RicksBoard director
Investors · 2
Sofinnova Ventureslisted by Sofinnova VenturesMenlo Park · $100K – $15M
How we know: Sofinnova Ventures's portfolio page · Not right? Tell us
Catalio Capital ManagementreportedNew York
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$348.9M disclosed across 1 round · 2026
▶$348.9MraisedMar 2026 · 104 investors · BiotechnologyRule 506(b)
▶$348.9MraisedMar 2026 · 104 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bob HolmenDirector
- Kristian HumerDirector
- Christopher GerryExecutive Officer, Director
- Phillip B. DonenbergDirector
- Anand Kiran ParikhExecutive Officer, Director
- Tom RicksDirector
- Josiah CraverExecutive Officer
- Offering amount
- $348.9M
- Amount sold
- $348.9M
- Sales commissions
- $11.7M
- Finders' fees
- $100K
- Placement agents
- Leerink Partners
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Sensei Biotherapeutics's investors?
- Sensei Biotherapeutics's investors include Sofinnova Ventures, Catalio Capital Management.
- How much funding has Sensei Biotherapeutics raised?
- Sensei Biotherapeutics has disclosed $348.9M raised across 1 round.
- Where is Sensei Biotherapeutics headquartered?
- Sensei Biotherapeutics is headquartered in Rockville, US.
